Kala Bio (KALA) Share-based Compensation (2016 - 2026)
Kala Bio (KALA) reported Share-based Compensation of -$136,000 for Q2 2026, compared with $2.24 million a year earlier.
Powered by 
Analysis
Kala Bio (KALA) Share-based Compensation (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kala Bio's Share-based Compensation came in at $4.06 million, down 53.2% year-over-year; for FY2025, it came in at $7 million, down 16.6% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -12.1% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $8.39 million in FY2024 (+12.4%), $7.46 million in FY2023 (+6.5%), $7.01 million in FY2022 (-56.4%) and $16.09 million in FY2021 (+20.9%).
- The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation in data going back to Q2 2016.
- Year over year, Share-based Compensation gained in two of the last seven quarters, with an average decline of 16.5%.
- The high point for year-over-year Share-based Compensation in five years was Q4 2023 (growth of 147.3%); the low point was Q4 2025 (a decline of 80.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.76 million (Q1 2026), $401,000 (Q4 2025) and $2.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Kala Bio | 2.38 Mn | -42.27 Mn | - | -136,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -136,000.00 |
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 401,000.00 |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 960,000.00 |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 2.81 Mn |
| Dec 31, 2021 | 2.75 Mn |
| Sep 30, 2021 | 3.93 Mn |
API Access
Kala Bio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();